AlphaCentric Advisors’s VivoSim Labs VIVS Stock Holding History

AlphaCentric Advisors’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,667	Closed	-$246K	–	222
2020 Q4	$246K	Buy	+1,667	New	+$190K	0.1%	56

Other funds holding VIVS

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AlphaCentric Advisors's VIVS Position: Q1 2021 in Review

AlphaCentric Advisors sold out of VivoSim Labs (VIVS) in Q1 2021, closing a stake of 1,667 shares — an estimated $246K sold.

AlphaCentric Advisors first reported a position in VIVS in Q4 2020 and held it in 1 quarter. The position peaked at $246K in Q4 2020. 45 funds tracked by Wall St. Rank hold VIVS as of Q1 2021.

AlphaCentric Advisors reported no remaining VivoSim Labs position as of Q1 2021 after selling out during the quarter.
AlphaCentric Advisors sold 1,667 VivoSim Labs shares in Q1 2021, an estimated $246K.
AlphaCentric Advisors first reported a position in VivoSim Labs in Q4 2020 and held it in 1 quarter.
AlphaCentric Advisors's VivoSim Labs position peaked at $246K in Q4 2020.
45 funds tracked by Wall St. Rank held VivoSim Labs as of Q1 2021.

Based on AlphaCentric Advisors's 13F filing for Q1 2021, filed 9 Mar 2022.